Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder
- PMID: 28658471
- PMCID: PMC5710548
- DOI: 10.1001/jamapsychiatry.2017.1472
Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder
Abstract
Importance: Individuals with attention-deficit/hyperactivity disorder (ADHD) are at greater risk for academic problems. Pharmacologic treatment is effective in reducing the core symptoms of ADHD, but it is unclear whether it helps to improve academic outcomes.
Objective: To investigate the association between the use of ADHD medication and performance on higher education entrance tests in individuals with ADHD.
Design, setting, and participants: This cohort study observed 61 640 individuals with a diagnosis of ADHD from January 1, 2006, to December 31, 2013. Records of their pharmacologic treatment were extracted from Swedish national registers along with data from the Swedish Scholastic Aptitude Test. Using a within-patient design, test scores when patients were taking medication for ADHD were compared with scores when they were not taking such medication. Data analysis was performed from November 24, 2015, to November 4, 2016.
Exposures: Periods with and without ADHD medication use.
Main outcomes and measures: Scores from the higher education entrance examination (score range, 1-200 points).
Results: Among 930 individuals (493 males and 437 females; mean [SD] age, 22.2 [3.2] years) who had taken multiple entrance tests (n = 2524) and used ADHD medications intermittently, the test scores were a mean of 4.80 points higher (95% CI, 2.26-7.34; P < .001) during periods they were taking medication vs nonmedicated periods, after adjusting for age and practice effects. Similar associations between ADHD medication use and test scores were detected in sensitivity analyses.
Conclusions and relevance: Individuals with ADHD had higher scores on the higher education entrance tests during periods they were taking ADHD medication vs nonmedicated periods. These findings suggest that ADHD medications may help ameliorate educationally relevant outcomes in individuals with ADHD.
Conflict of interest statement
Comment in
-
Efficacy of Stimulants Beyond Treatment of Core Symptoms of Attention-Deficit/Hyperactivity Disorder.JAMA Psychiatry. 2017 Aug 1;74(8):822-823. doi: 10.1001/jamapsychiatry.2017.1423. JAMA Psychiatry. 2017. PMID: 28658476 No abstract available.
Similar articles
-
Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.JAMA Psychiatry. 2017 Jun 1;74(6):597-603. doi: 10.1001/jamapsychiatry.2017.0659. JAMA Psychiatry. 2017. PMID: 28492937 Free PMC article.
-
Cumulative ADHD medication use and risk of type 2 diabetes in adults: a Swedish Register study.BMJ Ment Health. 2024 Sep 25;27(1):e301195. doi: 10.1136/bmjment-2024-301195. BMJ Ment Health. 2024. PMID: 39322586 Free PMC article.
-
Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder.Asia Pac Psychiatry. 2017 Mar;9(1). doi: 10.1111/appy.12231. Epub 2015 Dec 10. Asia Pac Psychiatry. 2017. PMID: 26663807
-
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.JAMA. 2016 May 10;315(18):1997-2008. doi: 10.1001/jama.2016.5453. JAMA. 2016. PMID: 27163988 Review.
-
The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.Can J Psychiatry. 2015 Feb;60(2):42-51. doi: 10.1177/070674371506000202. Can J Psychiatry. 2015. PMID: 25886655 Free PMC article. Review.
Cited by
-
Mediating pathways between attention deficit hyperactivity disorder and type 2 diabetes mellitus: evidence from a two-step and multivariable Mendelian randomization study.Epidemiol Psychiatr Sci. 2024 Oct 28;33:e54. doi: 10.1017/S2045796024000593. Epidemiol Psychiatr Sci. 2024. PMID: 39465621 Free PMC article.
-
ADHD and family life: A cross-sectional study of ADHD prevalence among pupils in China and factors associated with parental depression.PLoS One. 2024 Mar 14;19(3):e0281226. doi: 10.1371/journal.pone.0281226. eCollection 2024. PLoS One. 2024. PMID: 38483917 Free PMC article.
-
Attention-deficit/hyperactivity disorder.Nat Rev Dis Primers. 2024 Feb 22;10(1):11. doi: 10.1038/s41572-024-00495-0. Nat Rev Dis Primers. 2024. PMID: 38388701 Review.
-
Association between frequency of breakfast intake before and during pregnancy and developmental delays in children: the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.Nutr J. 2023 Dec 6;22(1):66. doi: 10.1186/s12937-023-00901-5. Nutr J. 2023. PMID: 38053088 Free PMC article.
-
Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.Brain Sci. 2022 Aug 1;12(8):1023. doi: 10.3390/brainsci12081023. Brain Sci. 2022. PMID: 36009086 Free PMC article. Review.
References
-
- Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-948. - PubMed
-
- Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994-e1001. - PubMed
-
- Faraone SV, Asherson P, Banaschewski T, et al. . Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015;1:15020. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
